Effect of Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors on Chronic Kidney Disease Progression: A Systematic Review
Chronic kidney disease (CKD) is a major global health concern characterized by progressive loss of kidney function and an increased risk of cardiovascular morbidity and mortality. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors, initially developed as antihyperglycemic agents for the treatment of type 2 diabetes mel...